[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# BioNTech

BioNTech and Bristol Myers Squibb presented promising Phase X data for their PD-L1xVEGF-A bispecific antibody, pumitamig, showing encouraging efficacy in advanced triple-negative breast cancer. This news has generated significant engagement across social media platforms.

### About BioNTech
BioNTech is a biotechnology company focused on developing and manufacturing innovative vaccines and therapeutics.  

### Engagements: XXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:biontech/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/biontech/time-series/interactions.tsv)  
Current Value: XXX  
Daily Average: XXXXXX  
X Week: XXX -XX%  
X Month: XXXXXX -XX%  
X Months: XXXXXXXXX -XX%  
X Year: XXXXXXXXXX -XX%  
1-Year High: XXXXXXX on 2025-03-17  
1-Year Low: X on 2025-11-10  

Engagements by network (24h):
Reddit: XXX
TikTok: XX
X: XXX
YouTube: XXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:biontech/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/biontech/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX -XX%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2024-12-21  
1-Year Low: X on 2025-11-10  

Mentions by network (24h):
Reddit: XX
TikTok: XX
X: XX
YouTube: XX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:biontech/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/biontech/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning BioNTech in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX -XX%  
X Months: XXXXX -XX%  
X Year: XXXXX -XX%  
1-Year High: XXX on 2024-12-21  
1-Year Low: X on 2025-11-10  

The most influential creators that mention BioNTech in the last XX hours

| Creator                        | Rank | Followers | Posts | Engagements |
| -------                        | ---- | --------- | ----- | ----------- |
| [@grok](/creator/twitter/grok) | X    | XXXXXXXXX | X     | X           |

[View More](/list/creators/biontech/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:biontech/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/biontech/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XX% -XX%  
X Month: XX% -XX%  
X Months: XX% -XX%  
X Year: XX% -XX%  
1-Year High: XXX% on 2025-10-29  
1-Year Low: XX% on 2025-04-17  

Most Supportive Themes:
- Cancer Drug Development: (30%) BioNTech is actively involved in developing new cancer drugs, with significant partnerships and investments being made in this area.
- Vaccine Manufacturing and Partnerships: (25%) BioNTech is expanding its vaccine manufacturing capabilities and forming strategic partnerships, including international collaborations.
- Financial Performance and Investments: (20%) The company's financial activities, including IPOs and significant deals, are generating interest and discussion.
  
Most Critical Themes:
- Bill Gates and Conspiracy Theories: (15%) There are ongoing discussions and conspiracy theories linking Bill Gates to BioNTech's success and the COVID-19 pandemic.
- Clinical Trial Integrity: (10%) Concerns are being raised about the integrity and potential manipulation of clinical trials conducted by pharmaceutical companies.
  

### Top BioNTech Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"We're Hiring in Rwanda Q-Sourcing seeks: X Utility Operator for Biontech X Territory Manager for TotalEnergies Marketing Rwanda Deadline: Dec XX 2025 🔗 Apply:"  
[X Link](https://x.com/QSSRwanda/status/1998724386988208254) [@QSSRwanda](/creator/x/QSSRwanda) 2025-12-10T12:00Z XXX followers, XXX engagements


"$BMY -XXXX% today as BioNTech and Bristol Myers Squibb Present First Global Phase X Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer More Info:"  
[X Link](https://x.com/OzmosiHealth/status/1998422038482956758) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T15:58Z 3014 followers, XXX engagements


"Big news from #SABCS25: BioNTech + Bristol Myers Squibb just dropped promising Phase X data for pumitamig a PD-L1 VEGF-A bispecific in pretreated triple-negative breast cancer.Key highlights: Encouraging ORR and PFS in a tough-to-treat population Potential first-in-class combo hitting both immune checkpoint and angiogenesis Another step forward for patients with TNBC who desperately need new options. #Oncology #Immunotherapy #BreastCancer Full data presented today in San Antonio"  
[X Link](https://x.com/PDUFA_Pulse/status/1998386826059620782) [@PDUFA_Pulse](/creator/x/PDUFA_Pulse) 2025-12-09T13:38Z XXX followers, XXX engagements


"BioNTech BMS flex upbeat interim mid-stage data for PD-L1/VEGF-A in TNBC #SABCS25 $BMY $BNTX"  
[X Link](https://x.com/fwpharma/status/1998374368938951006) [@fwpharma](/creator/x/fwpharma) 2025-12-09T12:49Z 55.1K followers, 1164 engagements